Friday, January 22, 2021

What is MIGS Glaucoma Treatment?

 


Glaucoma affects 2.7 million people in the United States, a number that is expected to grow to 6.3 million by 2050. The most common type of glaucoma-called Primary Open Angle Glaucoma is typically treated with eye drops or an in office laser treatment as the first option. In the past, if the disease progressed to moderate or advanced stage or wasn’t well controlled, ophthalmologists would perform an invasive surgical procedure called Trabeculectomy. Today, we are fortunate to have options called Minimally Invasive Glaucoma Surgery, or MIGS which offers a new option for patients with mild to moderate glaucoma, filling a gap between medication and more invasive Trabeculectomy procedures. MIGS is less invasive with quicker recovery times, has fewer complications and is also safer than Trabeculectomy.

If you or someone you know is over 40, or has other glaucoma risk factors such as family history or being of African-American or Hispanic heritage, please be sure to have annual eye exams with glaucoma testing as glaucoma vision loss can be prevented with early detection and treatment. Schedule an eye exam at D’Ambrosio Eye Care at 800-325-3937, visit D’Ambrosio Eye Care, or Facebook so that we can help.

D'Ambrosio Eye Care provides eye care for patients throughout greater Boston, central and western Massachusetts with office locations at 479 Old Union Turnpike, Lancaster, Massachusetts 01523, 865 Merriam Avenue, Suite 119, Leominster, Massachusetts 01453, 100 Powder Mill Road, Acton, Massachusetts 01720, 413 Main Street, Athol, Massachusetts 01331, 74 Main Street, Gardner, Massachusetts 01440 and 255 Park Avenue, Suite 606, Worcester, Massachusetts 01609.